Association of Clinical Research Professionals’ response to FDA draft guidance on diversity in clinical trials
Increased diversity in clinical trials should be a requirement, not a suggestion....
Increased diversity in clinical trials should be a requirement, not a suggestion....
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
Predictions for how clinical trials will evolve to better serve patients in 2023 and beyond....
A strong shift to decentralized clinical trials, regulatory changes, and an increased focus on diversity were among the main industry talking points in 2022....
Grant from US Centers for Disease Control and Prevention to advance public health workforce development at state and local levels over the next five years....
How to overcome barriers to increased patient diversity in clinical trials....
Innovation is led by visionaries who anticipate potential crises and adapt, as opposed to accepting chaos as the forced catalyst for change. Some of these visionaries are gifted women who may have once been underestimated and unrecognized for their talents....